ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
Rimas J Orentas, Paola Lopomo, William Babbitt, Marc Vigny, Crystal L Mackall
Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P27; DOI: 10.1186/2051-1426-1-S1-P27